The largest database of trusted experimental protocols

65 protocols using il 23

1

Stimulating Skin Cells with Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse dorsal skin cells were stimulated in culture with 40 ng/ml IL-23 (Biolegend, San Diego, CA, USA) alone or in combination with 40 ng/ml of IL-1β (eBioscience, Waltham, MA, USA) overnight. Supernatants were retained for cytokine analysis and cells were cultured with 10 mM Brefeldin A (Sigma Aldrich, Gillingham, UK) for 4-5 hours before staining for flow cytometric analysis. Alternatively, cells were stimulated with 50 ng/ml PMA and 500 ng/ml ionomycin (Sigma Aldrich, Gillingham, UK) and 10 mM Brefeldin A for 4 hours before staining for flow cytometric analysis. Similarly, small intestinal lamina propria cells were stimulated with 20 ng/ml IL- 23, IL-6, IL-2 (Biolegend, San Diego, CA, USA), and IL-1β in the presence of 10 μM Brefeldin A for 2 hours before PMA (50 ng/ml) and ionomycin (500 ng/ml) was added for a further 3 hours.
For co-culture of WT and CD200R1KO cells, dorsal skin cells were isolated and either the WT or CD200R1KO cells were labeled with 10 μM eF450-conjugated cell proliferation dye (eBioscience, Waltham, MA, USA) for 10 minutes in the dark at 37°C, then were washed and co-cultured with the unlabeled cells.
+ Open protocol
+ Expand
2

CD4+ T Cell Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocytes were isolated from peripheral lymph nodes and spleens of age- and sex- matched mice and purified with CD4 microbeads (L3T4, Miltenyi Biotec). Purified CD4+ T cells were cultured in RPMI 1640 medium containing 10% FBS, 1% penicillin-streptomycin and 2.6 μl of β-mercaptoethanol and activated with plate-coated 2.5 μg/ml anti-CD3 (145–2c11, BioXCell) and 1 μg/ml anti-CD28 (37.51, BioXCell) antibodies. For Treg differentiation, designated doses of TGF-β (2 ng/ml) and IL-2 (40 U/ml) were added into the culture medium. Rapamycin and mTOR inhibitors (pp242) were used as indicated. For Th1 differentiation, 20 ng/mL IL-12 (Biolegend) and 20 μg/mL anti-IL-4 (11B11, BioXcell) were added to the culture. For pathogenic Th17 cell differentiation, 20 ng/mL IL-1β (Biolegend), 20 ng/mL IL-6 (Biolegend), 50 ng/mL IL-23 (Biolegend) and 10 μg/mL anti-IFNγ (XMG1.2, BioXcell) were added to the culture. For classical Th17 cell differentiation, 1 ng/mL TGF-β (Biolegend), 40 ng/mL IL-6 (Biolegend) and 10 μg/mL anti-IFNγ (XMG1.2, BioXcell) were added to the culture. For CFSE proliferation assay, a final concentration of 2 μM of carboxyfluorescein succinimidyl ester (CFSE) (C1157, Life Technologies) was used to label CD4+ T cells.
+ Open protocol
+ Expand
3

Naïve CD4+ T cell differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were enriched from PBMCs by negative selection using magnetic beads (Miltenyi) and naïve CD45RA+CCR7+CD4+ T cells were then isolated by cell sorting using a BD FACSAria™ cytometer. Naïve CD4+ T cells were seeded at a concentration of 5 × 105 cells per well in a 96 well plate in complete medium and stimulated with anti-CD2/CD3/CD28 beads (Miltenyi) alone (TH0 condition) or in the presence of human recombinant cytokines: For TH1 conditions IL-12 (20ng/mL) (Biolegend); for TH17 conditions IL-6 (20ng/mL), IL-23 (10ng/mL) (Biolegend) and TGF-β1 (5 ng/mL) (R&D Systems); for TFH conditions IL-12 (2ng/mL), IL-23 (10 ng/mL) and TGF-β1 (5ng/mL)35 (link).
+ Open protocol
+ Expand
4

Listeria Infection and T Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Infection of mice with Listeria monocytogenes and subsequent analysis of T cell effector function were performed as previously described [27] (link), except that a cocktail of IL-23 (50 ng/ml; BioLegend), IL-1 (10 ng/ml; BioLegend), and Pam3Cys (1 μg/ml; Invivogen) was used to elicit IL-17 production from both γδ-17 and DN-17 cells.
+ Open protocol
+ Expand
5

Cytokine-Stimulated Skin and Intestinal Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse dorsal skin cells were stimulated in culture with 40 ng/mL IL-23 (Biolegend) alone, or in combination with 40 ng/mL IL-1β (eBioscience) overnight. Supernatants were retained for cytokine analysis and cells were cultured with 10 µM Brefeldin A (Sigma) for 4-5 hr before staining for flow cytometric analysis. Alternatively, cells were stimulated with 50 ng/mL PMA and 500 ng/mL ionomycin (Sigma) and 10 mM Brefeldin A for 4 hr before staining for flow cytometric analysis. Similarly, Small intestinal lamina propria cells were stimulated with 20 ng/mL IL-23, IL-6, IL-2 and IL-1β in the presence of 10 μM Brefeldin A for 2 hours, before PMA (50 ng/mL) and ionomycin (500 ng/mL) was added for a further 3 hours.
For co-culture of WT and CD200R1KO cells, dorsal skin cells were isolated and either the WT or CD200R1KO cells were labelled with 10 μM eF450-conjugated cell proliferation dye (Fischer Scientific) for 10 minutes in the dark at 37°C then were washed and co-cultured with the unlabelled cells.
+ Open protocol
+ Expand
6

Generation and Analysis of Th17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PBMCs were donated by Li Xia, who provided her written informed consent. All the cells were used in vitro only. The collection of human PBMCs was approved by the ethics committee of the Fudan Affiliated Minhang Hospital (2019-Pijian-010-01 K). Whole human blood was obtained from healthy volunteers, and peripheral blood mononuclear cells (PBMCs) were extracted from the whole blood using Ficoll (Fisher Scientific, Waltham, USA) centrifugation. CD3+ T cells purified from PBMCs were activated using anti-CD3/28 beads at a 1:1 ratio and polarized into type 17 T cells with human IL-1β (20 ng/ml, BioLegend, San Diego, CA), IL-6 (20 ng/ml, BioLegend, San Diego, CA), and IL-23 (50 ng/ml, BioLegend, San Diego, CA). After five days, the cytokine levels in the supernatant were determined using ELISA (Multisciences, Hangzhou, China). The cells were collected for flow cytometry analysis.
+ Open protocol
+ Expand
7

Cytokine Profiling in Serum and Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was obtained from the retro-orbital sinus, and serum was collected after blood coagulation. Wound edge tissue was collected in RIPA buffer and homogenized in the FastPrep instrument (Fastprep 24, Lysing Matrix D, MP Bio) per manufacturer’s protocol. The Bradford assay was performed to measure protein concentration of each sample. Serum and tissue IL-17A, IL-22, and IL-23 ELISAs were performed per the manufacturer’s instructions (Biolegend). Recombinant IL-17A, IL-22, or IL-23 was used as a positive control (Biolegend).
+ Open protocol
+ Expand
8

Cytokine-Induced Keratinocyte Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Medium was removed, and new medium containing cytokines was used to stimulate keratinocytes for a variety of time points. Unless stated otherwise, IL-6, IL-23, IL-27, IL-35 (all from BioLegend), and IL-12 (Tonbo) were added to 1 to 2 ml of medium at a concentration of 100 ng/ml; IFN-α (BioLegend) or IFN-γ (PeproTech) was added to 1 to 2 ml of media at a concentration of 50 U/ml. For the cytotoxicity study, cells were suspended in CellTiter 96 AQueous One Solution Reagent and then incubated at 37°C for 1 to 4 hours in a humidified, 5% CO2 atmosphere. Absorbance was read at 490 nm using a 24-well plate reader.
+ Open protocol
+ Expand
9

Quantifying Inflammatory Cytokine Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using blood samples collected from patients and control subjects as described in the flow cytometry section, we measured protein concentration with the bicinchoninic acid assay kit (BCA; Pierce, Appleton, WI, USA). The total protein concentration was adjusted to 1 mg/mL. The concentrations of TNF-α, CRP, IL-4, IL-6, IL-10, IL-17 (Sigma-Aldrich, St. Louis, MO, USA), IFN-γ (eBioscience, San Diego, CA), TGF-β (active; R&D Systems, Minneapolis, MN), and IL-23 (BioLegend, San Diego, CA, USA) were quantified by ELISA kits. Levels of TNF-α, CRP, IL-4, IL-6, IL-10, and IL-17 were measured within the range of the standard curve. The measurement range for the IFN-γ kit was 0.016 to 10 pg/mL, that for the TGF-β kit was 31.2 to 2000 pg/mL, and that for the IL-23 kit was 31.3 to 2000 pg/mL.
+ Open protocol
+ Expand
10

CD4+ T Cell Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocytes were isolated from peripheral lymph nodes and spleens of age- and sex- matched mice and purified with CD4 microbeads (L3T4, Miltenyi Biotec). Purified CD4+ T cells were cultured in RPMI 1640 medium containing 10% FBS, 1% penicillin-streptomycin and 2.6 μl of β-mercaptoethanol and activated with plate-coated 2.5 μg/ml anti-CD3 (145–2c11, BioXCell) and 1 μg/ml anti-CD28 (37.51, BioXCell) antibodies. For Treg differentiation, designated doses of TGF-β (2 ng/ml) and IL-2 (40 U/ml) were added into the culture medium. Rapamycin and mTOR inhibitors (pp242) were used as indicated. For Th1 differentiation, 20 ng/mL IL-12 (Biolegend) and 20 μg/mL anti-IL-4 (11B11, BioXcell) were added to the culture. For pathogenic Th17 cell differentiation, 20 ng/mL IL-1β (Biolegend), 20 ng/mL IL-6 (Biolegend), 50 ng/mL IL-23 (Biolegend) and 10 μg/mL anti-IFNγ (XMG1.2, BioXcell) were added to the culture. For classical Th17 cell differentiation, 1 ng/mL TGF-β (Biolegend), 40 ng/mL IL-6 (Biolegend) and 10 μg/mL anti-IFNγ (XMG1.2, BioXcell) were added to the culture. For CFSE proliferation assay, a final concentration of 2 μM of carboxyfluorescein succinimidyl ester (CFSE) (C1157, Life Technologies) was used to label CD4+ T cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!